Guidelines for Prevention and Treatment of Chronic Hepatitis B

To achieve the goal of the World Health Organization to eliminate viral hepatitis as a major public health threat by 2030, the Chinese Society of Infectious Diseases and the Chinese Society of Hepatology convened an expert panel in 2019 to update the guidelines for the prevention and treatment of ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Guiqiang, Duan, Zhongping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: XIA & HE Publishing Inc. 2021
Materias:
Guideline
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516840/
https://www.ncbi.nlm.nih.gov/pubmed/34722192
http://dx.doi.org/10.14218/JCTH.2021.00209
_version_ 1784583880470167552
author Wang, Guiqiang
Duan, Zhongping
author_facet Wang, Guiqiang
Duan, Zhongping
author_sort Wang, Guiqiang
collection PubMed
description To achieve the goal of the World Health Organization to eliminate viral hepatitis as a major public health threat by 2030, the Chinese Society of Infectious Diseases and the Chinese Society of Hepatology convened an expert panel in 2019 to update the guidelines for the prevention and treatment of chronic hepatitis B (CHB). The current guidelines cover recent advances in basic, clinical, and preventive studies of CHB infection and consider the actual situation in China. These guidelines are intended to provide support for the prevention, diagnosis, and treatment of CHB.
format Online
Article
Text
id pubmed-8516840
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher XIA & HE Publishing Inc.
record_format MEDLINE/PubMed
spelling pubmed-85168402021-10-28 Guidelines for Prevention and Treatment of Chronic Hepatitis B Wang, Guiqiang Duan, Zhongping J Clin Transl Hepatol Guideline To achieve the goal of the World Health Organization to eliminate viral hepatitis as a major public health threat by 2030, the Chinese Society of Infectious Diseases and the Chinese Society of Hepatology convened an expert panel in 2019 to update the guidelines for the prevention and treatment of chronic hepatitis B (CHB). The current guidelines cover recent advances in basic, clinical, and preventive studies of CHB infection and consider the actual situation in China. These guidelines are intended to provide support for the prevention, diagnosis, and treatment of CHB. XIA & HE Publishing Inc. 2021-10-28 2021-09-28 /pmc/articles/PMC8516840/ /pubmed/34722192 http://dx.doi.org/10.14218/JCTH.2021.00209 Text en © 2021 Authors. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Guideline
Wang, Guiqiang
Duan, Zhongping
Guidelines for Prevention and Treatment of Chronic Hepatitis B
title Guidelines for Prevention and Treatment of Chronic Hepatitis B
title_full Guidelines for Prevention and Treatment of Chronic Hepatitis B
title_fullStr Guidelines for Prevention and Treatment of Chronic Hepatitis B
title_full_unstemmed Guidelines for Prevention and Treatment of Chronic Hepatitis B
title_short Guidelines for Prevention and Treatment of Chronic Hepatitis B
title_sort guidelines for prevention and treatment of chronic hepatitis b
topic Guideline
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516840/
https://www.ncbi.nlm.nih.gov/pubmed/34722192
http://dx.doi.org/10.14218/JCTH.2021.00209
work_keys_str_mv AT wangguiqiang guidelinesforpreventionandtreatmentofchronichepatitisb
AT duanzhongping guidelinesforpreventionandtreatmentofchronichepatitisb

Ejemplares similares